In AML models, CK2 genetic silencing and pharmacological inhibition did not result in exclusion of SET from the cytosol of AML cells, indicating that targeting a single kinase might not be sufficient to release PP2A from SET inhibition [99]. The gene discussed is SET; the disease is acute myeloid leukemia.